Some prostate-cancer doctors are using a genomics test to figure out which patients need surgery and which ones can follow ‘active surveillance.’
WSJ.com US News, Wall Street Journal
Sat, 03/31/2018 - 7:57am
Some prostate-cancer doctors are using a genomics test to figure out which patients need surgery and which ones can follow ‘active surveillance.’